Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.
from NYT > Health https://ift.tt/3gHE1e6
December 13, 2020
Rose
Health - The New York Times, NYT > Health
No comments
Related Posts:
Cruises and the Coronavirus: What Passengers Need to KnowCompanies are changing policies and procedures as the outbreak has travelers worried and bookings softening. from Health https://ift.tt/38huyEE … Read More
The Fashion World, Upended by CoronavirusThe growing coronavirus threat chased the luxury fashion world from Milan to Paris. A real crisis looms for designers, retailers and shoppers. from Health https://ift.tt/3axaGyD … Read More
‘No Way Out’: In China, Coronavirus Takes Toll on Other PatientsThe outbreak is straining a health care system that was already overburdened, and many patients with other illnesses are now falling through the cracks. from Health https://ift.tt/2PJaDbg … Read More
U.S. Will Drop Limits on Virus Testing, Pence SaysPresident Trump was weighing more restrictions on travelers arriving from abroad. The U.S. death toll rose to nine, including two who died last week and were later confirmed to have been infected. from Health https://ift.tt/… Read More
How Exercise May Affect Your ImmunityDoes exercise help or hinder our bodies’ ability to fight off infections? It depends. from Health https://ift.tt/3cu27GG … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment